Inovio Pharmaceuticals Inc $ 17 1.33 (8.49%)
Warning! GuruFocus has detected 5 Severe warning signs with INO. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for Inovio Pharmaceuticals Inc () from 1998 to Sep 19 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Inovio Pharmaceuticals stock (INO) PE ratio as of Sep 19 2020 is 0. More Details
Inovio Pharmaceuticals PE Ratio (TTM) Historical Data
View and export this data going back to 1998. Start your Free Trial
Inovio Pharmaceuticals PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare NAS:KRTX NAS:RARX NAS:PRNB NAS:TPTX NAS:SAGE NYSE:ADCT NAS:RVMD NAS:TGTX NAS:MDGL NAS:EPZM OCSE:NOVO B ASX:CSL NAS:VRTX NAS:REGN XKRX:207940 NAS:SGEN NAS:MRNA NAS:ALXN XKRX:068270 NAS:INCY
Address 660 West Germantown Pike, Suite 110, Plymouth Meeting, PA, USA, 19462
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.